Clinical Trial Update: Longitudinal Bladder Cancer Study for Tumour Recurrence

View source ↗

Summary

A recruiting longitudinal study evaluating biomarker testing for monitoring tumour recurrence in bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Pacific Edge Limited | Conditions: Urothelial Bladder Cancer | Status: RECRUITING